Journal article
Pilot drug and therapeutic committee programme in Sierra Leone: A descriptive mixed method study
British Journal of Clinical Pharmacology, pp.1-14
2021
PMID: 33398910
Metrics
18 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Abstract
Irrational medicine use is a global crisis, but incidences are proportionately higher in low- and middle-income countries such as Sierra Leone. This study explores the structure, functions and challenges of drug and therapeutics committees (DTCs), an intervention towards irrational medicine use recently piloted in Sierra Leone.
A 2-phase mixed-method study design was used in this study. Firstly, a cross-sectional survey was conducted on all pharmacists who have worked for at least 1 year in DTC-piloted hospitals, using an online questionnaire to assess DTCs' structure, indicators and challenges. In phase 2, all eligible pharmacists were invited for a semistructured online interview using the WhatsApp messaging application to get deeper insights into the key issues that emerged from the survey; however, only 5 of the 7 consented to participate. MS Excel 2019 and NVivo version 12 were respectively used for data management and analysis.
A total of 6 survey responses and 5 interviews were included in the analysis. Participants are pharmacists from the 7 hospitals in Sierra Leone where DTC was piloted. Most DTCs are comprised of a minimum of 10 members consisting of both medical and hospital administrative staff. The main functions of DTCs are ensuring rational medicines use, monitoring and reporting adverse drug reactions. All 7 hospitals with established pilot DTCs have different subcommittees operating at varying functionality levels, ranging from effective to nonfunctional. The main challenges in DTC functions and maintenance are funding (n = 6), DTC decision implementation (n = 4), and unmotivated members (n = 4). Strategies suggested to improve DTCs at public hospitals and nationwide include resource allocation, monitoring and evaluating DTC functions and its members' capacity building.
DTCs present a compelling opportunity towards achieving rational medicines use at the hospital level in Sierra Leone. Nonetheless, the lack of funding and operational resources are significant limitations that must be noted by policymakers before expanding DTC programmes to other hospitals in Sierra Leone.
Details
- Title
- Pilot drug and therapeutic committee programme in Sierra Leone: A descriptive mixed method study
- Creators
- John Alimamy Kabba (Author) - Xi'an Jiaotong UniversityMark Momoh Koroma (Author) - Southern Medical UniversityPeter Bai James (Author) - University of Technology SydneyChenai Kitchen (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)Sen Xu (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)Jie Chang (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)Amna Saeed (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)Usman Rashid Malik (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)Minghuan Jiang (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)Yu Fang (Author) - Institute of Pharmaceutical Science and Technology(Xi'an, China)
- Publication Details
- British Journal of Clinical Pharmacology, pp.1-14
- Identifiers
- 991012922900102368
- Academic Unit
- Faculty of Health; National Centre for Naturopathic Medicine
- Language
- English
- Resource Type
- Journal article